
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.05 | 3.14465408805 | 1.59 | 1.775 | 1.5 | 2296757 | 1.64176112 | CS |
4 | -1.33 | -44.7811447811 | 2.97 | 3.46 | 1.26 | 3763589 | 1.91682746 | CS |
12 | -11.7 | -87.7061469265 | 13.34 | 14.255 | 1.26 | 2637706 | 3.41118027 | CS |
26 | -10.76 | -86.7741935484 | 12.4 | 16.1 | 1.26 | 1457777 | 5.32149772 | CS |
52 | -13.06 | -88.843537415 | 14.7 | 16.52 | 1.26 | 950630 | 7.1315147 | CS |
156 | -6.62 | -80.1452784504 | 8.26 | 36.64 | 1.26 | 818253 | 15.59809565 | CS |
260 | -20.86 | -92.7111111111 | 22.5 | 43.92 | 1.26 | 559985 | 16.35349405 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約